SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
OMEGA THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 68217N105
Event date: 2024-12-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Flagship V VentureLabs Rx Fund, L.P.Reported CIK 0001724939
Shares: 1,088,470 · Class: 2%
- Flagship Ventures Fund V, L.P.Reported CIK 0001627639
Shares: 5,896,386 · Class: 10.6%
- Flagship Ventures Fund V General Partner LLCReported CIK 0001724575
Shares: 6,984,856 · Class: 12.6%
- Flagship Pioneering Fund VI, L.P.Reported CIK 0001716926
Shares: 8,617,413 · Class: 15.6%
- Flagship Pioneering Fund VI General Partner LLCReported CIK 0001724957
Shares: 8,617,413 · Class: 1.8%
- Nutritional Health LTP Fund, L.P.Reported CIK 0001780956
Shares: 970,588 · Class: 1.8%
- Nutritional Health LTP Fund General Partner LLCReported CIK 0001780951
Shares: 970,588 · Class: 1.8%
- Flagship Pioneering Special Opportunities Fund II, L.P.Reported CIK 0001760283
Shares: 7,508,693 · Class: 13.6%
- Flagship Pioneering Special Opportunities Fund II General Partner LLCReported CIK 0001826217
Shares: 7,508,693 · Class: 13.6%
- FPN, L.P.Reported CIK 0001860062
Shares: 1,617,646 · Class: 2.9%
- FPN General Partner LLCReported CIK 0001860059
Shares: 1,617,646 · Class: 2.9%
- Flagship VentureLabs V, LLCReported CIK 0001724959
Shares: 2,197,059 · Class: 4%
- Flagship VentureLabs V Manager LLCReported CIK 0001768987
Shares: 2,197,059 · Class: 4%
- Flagship Pioneering Fund VII, L.P.Reported CIK 0001805916
Shares: 1,329,324 · Class: 2.4%
- Flagship Pioneering Fund VII General Partner LLCReported CIK 0001805917
Shares: 1,329,324 · Class: 2.4%
- Flagship Pioneering, Inc.Reported CIK 0001400240
Shares: 22,240,723 · Class: 40.2%
- Noubar AfeyanReported CIK 0001222012
Shares: 29,225,579 · Class: 52.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-24-141669
- Form type
- SCHEDULE 13D/A
- Filer
- Flagship Ventures Fund V, L.P.
- CIK
- CIK 1627639
- Filed
- Dec 31, 2024
- Reporting period
- Dec 29, 2024
- Description
- Schedule 13D beneficial ownership